GMEDNYSE

Globus Medical Inc.

Healthcare·Healthcare·Commercial·Audubon, PA, United States

Globus Medical Inc. (GMED): 222 pipeline candidates · ~10 mo cash runway · 2 clinical trials. Updated within the last hour.

6.1/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway2.7

9.8 months

Financial Health9.6

D/E 0.15

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

222 candidates

Catalyst MomentumN/A

N/A

Insider Signal2.2

0 buys · 4 sells (180d)

A transparent, data-derived signal for Globus Medical Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$10.6B

Cash

$561.0M

Quarterly Burn

$334.3M

Runway

9.8 mo

Revenue

$759.9M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Apr 2027
Today~11 mo out
Catalyst within runway

Pipeline (222 candidates)

Showing 10 of 222 candidates. Sign up for full pipeline.

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

598

Total value held

$9.34B

HolderSharesValue
janus henderson group plc15,246,190$1.31B
blackrock, inc.10,497,414$904.5M
vanguard capital management llc10,065,464$867.2M
vanguard portfolio management llc4,879,459$420.4M
state street corp3,590,372$309.3M
bank of montreal /can/2,307,181$198.8M
geode capital management, llc2,112,124$182.0M
citadel advisors llc2,029,114$174.8M
william blair investment management, llc2,009,763$173.2M
alliancebernstein l.p.1,750,832$152.9M

Showing top 10 of 598 institutional holders of Globus Medical Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

2 clinical trials·172 FDA decisions·CEO: Mr. Keith W. Pfeil

Frequently asked questions

How many drug candidates are in Globus Medical Inc.'s pipeline?

Globus Medical Inc. (GMED) has 222 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Globus Medical Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Globus Medical Inc. has approximately 9.8 months of cash runway.

What is Globus Medical Inc.'s market capitalization?

Globus Medical Inc.'s market capitalization is approximately $10.6B.

Who is the CEO of Globus Medical Inc.?

Mr. Keith W. Pfeil is the chief executive officer of Globus Medical Inc. (GMED).

Get the full picture on Globus Medical Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.